Jacobus Pharmaceutical: Clinical Trials

14 trials sponsored by Jacobus Pharmaceutical, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 3 no longer available. 5 Phase 2, 2 Not applicable, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 4, Completed 1
Not applicable2Completed 2
Phase 12Completed 2
Phase 32Completed 2

Follow Jacobus Pharmaceutical: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Continuous 3,4-DAP, Taper 3,4-DAP to Placebo - Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome
Phase 2CompletedJacobus Pharmaceutical322012-01-012017-07-11
High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
4-Aminosalicylic acid extended release granules - Crohn's Disease
Phase 2TerminatedJacobus Pharmaceutical22007-06-012017-09-21
High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
4-Aminosalicylic acid, PASER placebo granules - Crohn's Disease
Phase 2TerminatedJacobus Pharmaceutical542007-01-012008-10-15
Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
3-4 Diaminopyridine - Muscle Weakness
Phase 2TerminatedJeffrey A. Cohen, MD42004-02-012019-05-21
Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
Dapsone - Pemphigus Vulgaris
Phase 2TerminatedJacobus Pharmaceutical481996-11-012007-02-05
Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia
Trimetrexate glucuronate, Trimethoprim, Sulfamethoxazole - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 1CompletedU.S. Bioscience202005-06-24
A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
Pentamidine isethionate, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)4002021-11-01
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
3,4 diaminopyridine - Lambert-Eaton Myasthenic Syndrome
No longer availableDavid Lacomis, MD2019-07-09
3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
3,4-diaminopyridine - Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM)
No longer availableOregon Health and Science University2019-12-11
Treatment of Lambert-Eaton Syndrome With 3,4 DAP
3, 4 DAP - Lambert Eaton Myasthenic Syndrome
No longer availableDavid P. Richman, MD2019-10-30
A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
Primaquine, Sulfamethoxazole-Trimethoprim, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2902021-11-03
A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
Trimethoprim, Sulfamethoxazole, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections
Not applicableCompletedJacobus Pharmaceutical2005-06-24
Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)
Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections
Not applicableCompletedJacobus Pharmaceutical2005-06-24
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)962021-11-04

Conditions studied

HIV Infections (6)  ·  Pneumonia, Pneumocystis (6)  ·  Acquired Immunodeficiency Syndrome (5)  ·  Lambert-Eaton Myasthenic Syndrome (4)  ·  AIDS-Related Complex (3)  ·  AIDS-Related Opportunistic Infections (2)  ·  Crohn Disease (2)  ·  Candidiasis, Oral (1)  ·  Leukoplakia, Oral (1)  ·  Muscle Weakness (1)  ·  Myasthenic Syndromes, Congenital (1)  ·  Pediatric Crohn's disease (1)  ·  Pemphigus (1)  ·  Primary Dysautonomias (1)  ·  Reflex, Abnormal (1)

Interventions

Dapsone (7)  ·  Amifampridine (4)  ·  Aminosalicylic Acid (2)  ·  Sulfamethoxazole (2)  ·  Trimethoprim (2)  ·  Clindamycin (1)  ·  Leucovorin (1)  ·  Pentamidine (1)  ·  Primaquine (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  trimetrexate glucuronate (1)

Countries

United States (13)  ·  Israel (1)  ·  Puerto Rico (1)

Top investigators

Amit Pandya, MD (1)  ·  Black JR (1)  ·  Cooper E (1)  ·  Daniel Present, MD (1)  ·  David P Jacobus, MD (1)  ·  David P. Jacobus, MD (1)  ·  David Richman, MD (1)  ·  Diana Chen, MD (1)  ·  El-Sadr W (1)  ·  George D Ferry, MD (1)  ·  Iris Dotan, MD (1)  ·  Jeffrey A. Cohen, MD (1)  ·  Joel R Rosh, MD (1)  ·  John Hanson, MD (1)  ·  Kathy L Ales, MD (1)

Results publications

PMID 18209165